ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Gianni D. Angelini
Sudath P. Talpahewa
Raimondo Ascione
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jeremy, J. Y.
Right arrow Articles by Ascione, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jeremy, J. Y.
Right arrow Articles by Ascione, R.
Related Collections
Right arrow Coronary disease

Ann Thorac Surg 2002;74:1553-1557
© 2002 The Society of Thoracic Surgeons


Original article: cardiovascular

Sustained increases of plasma homocysteine, copper, and serum ceruloplasmin after coronary artery bypass grafting

Jamie Y. Jeremy, PhDa*, Nilima Shukla, PhDa, Gianni D. Angelini, FRCSa, Andrew Day, FRCPb, Innes Y.P. Wan, FRCSa, Sudath P. Talpahewa, FRCSa, Raimondo Ascione, FRCSa

a Bristol Heart Institute, Bristol, United Kingdom
b Department of Clinical Biochemistry, University of Bristol, Bristol Royal Infirmary, Bristol, United Kingdom

Accepted for publication May 19, 2002.

* Address reprint requests to Dr Jeremy, Bristol Heart Institute, Bristol Royal Infirmary, Bristol BS2 8HW, United Kingdom.
e-mail: j.y.jeremy{at}bris.ac.uk

Background. Homocysteine (Hcy) is an independent risk factor for coronary artery disease, but there are no reports on Hcy levels in patients undergoing coronary artery bypass graft (CABG) surgery. Interactions between Hcy and copper may mediate the vasculopathic impact of Hcy, and this may play a role in vein graft failure. The aim of this study was to assess the perioperative levels of Hcy, copper, ceruloplasmin (CP), folate, and vitamin B12 in patients undergoing myocardial revascularization surgery.

Methods. Blood samples were taken from 55 consecutive patients undergoing elective conventional CABG (43 male; mean age, 63.2 ± 5.2 years) 1 day preoperatively and postoperatively at 1 day, 6 days, and 6 weeks. Hcy, copper, CP, red cell folate, vitamin B12, creatinine, and C-reactive protein (CRP) were then measured using standard clinical chemistry methods. The same protocol was applied to 10 patients (7 male; mean age, 63.3 ± 5.2 years) undergoing off-pump coronary artery bypass (OPCAB) surgery.

Results. In the conventional CABG group, there were significant increases in the plasma concentrations at 6 days and 6 weeks postoperatively of Hcy (from 10.1 to 11.6 and 13.5 µmol/L, respectively), plasma copper (from 13.5 to 20.3 and 18.5 µmol/L), and serum ceruloplasmin (from 0.3 to 0.41 and 0.44 g/L). CRP and vitamin B12 were elevated at 6 days but not 6 weeks after the operation. In contrast, red cell folate and creatinine were not significantly changed. The subgroup analysis for the OPCAB patients showed the same trend as for the conventional group.

Conclusions. Coronary surgery precipitates a significant and sustained increase in the blood concentrations of Hcy and copper, which is not due to a decrease in folate and vitamin B12, altered renal function, or inflammation. Further studies are required to establish whether the concomitant increase in Hcy and copper plays an etiological role in vein graft disease.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
N. Shukla, G. D. Angelini, and J. Y. Jeremy
Interactive Effects of Homocysteine and Copper on Angiogenesis in Porcine Isolated Saphenous Vein
Ann. Thorac. Surg., July 1, 2007; 84(1): 43 - 49.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. Wan, N. Shukla, A. P.C. Yim, J. L. Johnson, G. D. Angelini, and J. Y. Jeremy
Orally administered penicillamine is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts
J. Thorac. Cardiovasc. Surg., February 1, 2007; 133(2): 494 - 500.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
S. Storti, A. G. Cerillo, A. Rizza, I. Giannelli, G. Fontani, M. Glauber, and A. Clerico
Coronary artery bypass grafting surgery is associated with a marked reduction in serum homocysteine and folate levels in the early postoperative period
Eur. J. Cardiothorac. Surg., October 1, 2004; 26(4): 682 - 686.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 by The Society of Thoracic Surgeons.